These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 3973511)
41. Isoform heterogeneity and lipid affinity of human lymph and plasma apolipoprotein A-IV. Weinberg RB; Spector MS Biochem Biophys Res Commun; 1985 Jun; 129(2):576-83. PubMed ID: 4015646 [TBL] [Abstract][Full Text] [Related]
42. Regulation of apoprotein synthesis and secretion in the human hepatoma Hep G2. The effect of exogenous lipoprotein. Craig WY; Nutik R; Cooper AD J Biol Chem; 1988 Sep; 263(27):13880-90. PubMed ID: 2843542 [TBL] [Abstract][Full Text] [Related]
43. Adsorption of apolipoprotein A-IV to phospholipid monolayers spread at the air/water interface. A model for its labile binding to high density lipoproteins. Weinberg RB; Ibdah JA; Phillips MC J Biol Chem; 1992 May; 267(13):8977-83. PubMed ID: 1577735 [TBL] [Abstract][Full Text] [Related]
44. Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins. Liang HQ; Rye KA; Barter PJ J Lipid Res; 1994 Jul; 35(7):1187-99. PubMed ID: 7964180 [TBL] [Abstract][Full Text] [Related]
45. Interactions of apolipoprotein A-I with high-density lipoprotein particles. Nguyen D; Nickel M; Mizuguchi C; Saito H; Lund-Katz S; Phillips MC Biochemistry; 2013 Mar; 52(11):1963-72. PubMed ID: 23425306 [TBL] [Abstract][Full Text] [Related]
46. Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes. Masson D; Pais de Barros JP; Zak Z; Gautier T; Le Guern N; Assem M; Chisholm JW; Paterniti JR; Lagrost L J Lipid Res; 2006 Feb; 47(2):356-65. PubMed ID: 16282639 [TBL] [Abstract][Full Text] [Related]
47. Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase. Mowri HO; Patsch JR; Gotto AM; Patsch W Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):755-62. PubMed ID: 8640403 [TBL] [Abstract][Full Text] [Related]
48. Effect of a neutralizing monoclonal antibody to cholesteryl ester transfer protein on the redistribution of apolipoproteins A-IV and E among human lipoproteins. Bisgaier CL; Siebenkas MV; Hesler CB; Swenson TL; Blum CB; Marcel YL; Milne RW; Glickman RM; Tall AR J Lipid Res; 1989 Jul; 30(7):1025-31. PubMed ID: 2794785 [TBL] [Abstract][Full Text] [Related]
49. Interaction of human plasma high density lipoprotein HDL2 with synthetic saturated phosphatidylcholines. Gong EL; Nichols AV Lipids; 1980 Feb; 15(2):86-90. PubMed ID: 6768948 [TBL] [Abstract][Full Text] [Related]
50. Distribution of apolipoproteins A-I and B among intestinal lipoproteins. Alpers DH; Lock DR; Lancaster N; Poksay K; Schonfeld G J Lipid Res; 1985 Jan; 26(1):1-10. PubMed ID: 3919131 [TBL] [Abstract][Full Text] [Related]
51. Plasma lipoproteins in the golden Syrian hamster (Mesocricetus auratus): heterogeneity of apoB- and apoA-I-containing particles. Goulinet S; Chapman MJ J Lipid Res; 1993 Jun; 34(6):943-59. PubMed ID: 8354960 [TBL] [Abstract][Full Text] [Related]
52. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. Windler E; Havel RJ J Lipid Res; 1985 May; 26(5):556-65. PubMed ID: 4020294 [TBL] [Abstract][Full Text] [Related]
53. Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro. Tam SP; Dory L; Rubinstein D J Lipid Res; 1981 May; 22(4):641-51. PubMed ID: 7276737 [TBL] [Abstract][Full Text] [Related]
55. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. Havel RJ; Kane JP; Kashyap ML J Clin Invest; 1973 Jan; 52(1):32-8. PubMed ID: 4345202 [TBL] [Abstract][Full Text] [Related]
56. Human apolipoprotein A-II inhibits the formation of pre-beta high density lipoproteins. Calabresi L; Lucchini A; Vecchio G; Sirtori CR; Franceschini G Biochim Biophys Acta; 1996 Nov; 1304(1):32-42. PubMed ID: 8944748 [TBL] [Abstract][Full Text] [Related]
57. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity. Guyard-Dangremont V; Lagrost L; Gambert P J Lipid Res; 1994 Jun; 35(6):982-92. PubMed ID: 8077854 [TBL] [Abstract][Full Text] [Related]
58. Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants. Jonas A; von Eckardstein A; Kézdy KE; Steinmetz A; Assmann G J Lipid Res; 1991 Jan; 32(1):97-106. PubMed ID: 1901346 [TBL] [Abstract][Full Text] [Related]
59. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis. Vergnes L; Baroukh N; Ostos MA; Castro G; Duverger N; Nanjee MN; Najib J; Fruchart JC; Miller NE; Zakin MM; Ochoa A Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2267-74. PubMed ID: 11031214 [TBL] [Abstract][Full Text] [Related]
60. The role of lecithin: cholesterol acyltransferase in high density lipoprotein3/high density lipoprotein2 interconversion. Schmitz G; Assmann G; Melnik B Clin Chim Acta; 1982 Mar; 119(3):225-36. PubMed ID: 7067121 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]